Categories: Press-Releases

Bronstein, Gewirtz & Grossman, LLC Announces Twist Bioscience Corporation (TWST) Investigation

[ad_2]

NEW YORK, Dec. 7, 2022 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Investors who purchased Twist securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/twst.

The investigation concerns whether Twist violated federal securities laws.

On November 15, 2022, Scorpion Capital published a short report on Twist (the “Scorpion Report”). The Scorpion Report described Twist as “[t]he latest miniaturized ‘lab-on-a-chip’ scam, just like Theranos, Berkeley Lights, and other failures” and “[a] ticking time bomb that we believe is resorting to a Worldcom-esque accounting fraud”. The Scorpion Report alleged that “Twist’s reported gross margins of 45% are simply implausible” and claimed that “[m]ultiple competitors internally refer to Twist’s price dumping and customer subsidy scheme as a ‘Ponzi'”. Following publication of the Scorpion Report, Twist’s stock price fell $7.57 per share, or 19.92%, to close at $30.43 per share on November 15, 2022.

If you are aware of any facts relating to this investigation or purchased Twist securities, you can assist this investigation by visiting the firm’s site: www.bgandg.com/twst. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bronstein-gewirtz–grossman-llc-announces-twist-bioscience-corporation-twst-investigation-301697476.html

SOURCE Bronstein, Gewirtz & Grossman, LLC



Source link
[ad_2]
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

[ad_2]

PR Newswire

Recent Posts

Share repurchase programme

[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…

1 week ago

Gyroscope Market Size, Share And Growth Analysis For 2024-2033

[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…

1 week ago

Casting Off the Caste System and its Stigma: Empowering the Forgotten Indigenous People of India with Human Rights

[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…

1 week ago

Alipay+ Enables Digital Payment of 14 Overseas E-wallets from 9 Countries and Regions in Hong Kong to Support City’s Global Travel Drive

In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…

1 week ago

Celebrate "Bleach: Brave Souls" Reaching Over 90 Million Downloads Worldwide with "The Future Society Zenith Summons: Cyber" Featuring New Versions of Ulquiorra, Orihime, and Nnoitora

[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…

1 week ago

TransAlta Declares Dividends

[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…

1 week ago